Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, November 25, 2009, 8:49am SGT - The Singapore stock market opens in 11 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Valeant Pharmaceuticals International (VRX)
At 5:02AM SGT:
32.85 USD
0.25 (0.77%)
MORE ON VRX
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
VALEANT PHARMA INTL
(NYSE:VRX) Delayed quote data
After Hours:
32.70
0.15 (0.46%)
as of 5:03am SGT on 11/25/09
Last Trade:
32.85 USD
Trade Time:
5:02AM SGT
Change:
0.25 (0.77%)
Prev Close:
32.60
Open:
32.66
Bid:
N/A
Ask:
N/A
1y Target Est:
24.57
Day's Range:
32.30 - 32.90
52wk Range:
15.64 - 34.44
Volume:
489,093
Avg Vol
(3m)
:
806,442
Market Cap:
2.67B
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.64
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add VRX to Portfolio
Download Data
HEADLINES
Valeant Pharma begins selling generic IBS drug
AP
(Tue 4:46am)
[$$] Valeant Shares Fall Ill
at Barrons.com
(Tue 3:03am)
Barron's Magazine First Read: Dividends, VRX, DISCA
at Barrons.com
(Mon, Nov 23)
Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
PR Newswire
(Mon, Nov 23)
Valeant may fall if new drug disappoints-Barron's
at Reuters
(Mon, Nov 23)
This Weekend's Barron's: Dividend Paying Stocks; BB&T Is the Banking Belle of the South; Is There Any Hope for Atlantic City
at Barrons.com
(Sat, Nov 21)
[$$] Hot Drug Stock in Need of a Chill Pill
at Barrons.com
(Sat, Nov 21)
Drugmaker Reinvents Itself And Expands Footprint Internationally
Investor's Business Daily
(Thu, Nov 19)
Big Value in Valeant
RealMoney by TheStreet.com
(Thu, Nov 12)
VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal
EDGAR Online
(Wed, Nov 11)
UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector
Wall Street Transcript
(Wed, Nov 11)
More Headlines for VRX...
ANALYST
EPS Est (next year)
(Dec-09)
:
2.04
EPS Est (in 2 years)
(Dec-10)
:
2.27
Avg Rec (current)*:
3.6
PEG Ratio:
0.93
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices